Company News & Press
Load more
Find Us at These Events
20 January 2021
Webinar: Unique advantages of incorporating untargeted and targeted metabolomics in drug development and clinical trials
January 20th 10:00 am EDT/16:00 CEST Successful drug development hinges on multimillion-dollar decisions about the mechanism of action, safety, dosage,...
18 November 2020
Webinar: Deeper Understanding of COVID-19 Phenotypes Through Metabolomics: A Panel Discussion
November 18th 9:00 am EDT/15:00 CEST How are researchers studying COVID-19 using metabolomics to get closer to the phenotype? Seven...
23 September 2020
Webinar: Mechanisms of Immune Control and Metabolomics
September 23rd 7:00 am EDT/13:00 CEST Across the globe, 37.9 million people are living with HIV (PLWH). With access to...
21 September 2020
Event: BioProcess International
Visit us at booth 610
Connect with 2000+ global scientists, engineers and executives working across the entire spectrum of biopharmaceutical development and production.
14 September 2020
Presentation: Leveraging Global Metabolomics at the Intersection of Physiology and Behavior (at MANA 2020)
September 14th 12:00 pm EDT Metabolomics offers researchers the ability to get closer to the phenotype by identifying small molecules...
IGES is the International Genetic Epidemiology Society, a scientific society concerned with “the study of genetic components in complex biological phenomena” according to James V. Neel, the founding President of the Society. The successful mapping of the human genome will greatly facilitate the study of health and disease in a manner that integrates both host and environmental factors.
27 May 2020
Webinar: Driving COVID-19 Research Forward
Join Metabolon’s Patricia Sheridan, Ph.D., Senior Study Director, Discovery & Translational Sciences, for a conversation with Dr. Heath on May 27th at 11:00 am EDT/13:00 CEST. They will be discussing some of the current work that ISB is doing to explore COVID-19 infections and how metabolomics can be used to understand the pathophysiology of the infection.
Leveraging Machine Learning to Advance Precision Medicine
National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study
Metabolon, Inc. Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies